Trending Psychedelic Science Research Papers | OpenScience.ink

3 days ago • Frontiers in psychiatry

How letting go, distancing, and rethinking relate to psilocybin response in hard-to-treat OCDSurrender, disidentification, and reappraisal: a qualitative comparison of psilocybin responders and non-responders in treatment-resistant OCD.

📖 Top 20% JournalArticle

4 days ago • Psychopharmacology

How Psychedelic Therapy May Reset Memory Storage to Help Anxiety DisordersResetting the hippocampal buffer: a neurocognitive account of psychedelic therapy for anxiety-related psychopathology.

📖 Top 20% JournalArticle

3 days ago • Frontiers in neuroscience

What Brain Flexibility Means in Mental Health and How Psychedelic Therapy May Relate to ItOn the meaning of "plasticity" in neuroscience and mental health research and its relation to the action of psychedelic therapy.

📖 Top 20% JournalArticle

3 days ago • JAMA psychiatry

Why Stronger Blinding Is Needed in Psychedelic Drug StudiesThe Case for More Aggressive Masking in Psychedelic Trials.

🥇 Top 1% JournalArticle

4 days ago • Scientific reports

Computer study of how dimethyltryptamine attaches to and is detected by metal-doped C20 fullereneIn silico insights into the adsorption and detection of dimethyltryptamine on metal doped C20 fullerene.

📖 Top 20% JournalArticle

6 days ago • Orvosi hetilap

Using Psychedelic Drugs in Mental Health Treatment[The use of psychedelics in psychiatry].

English Abstract

4 days ago • Molecules (Basel, Switzerland)

Comparing the Safety and Effectiveness of Mushroom-Based and Plant-Based Treatments for Mental HealthSafety and Efficacy of Natural and Conventional Psychiatric Treatments: A Comparative Review of Mushroom-Derived Compounds and Medicinal Plants in the Management of Mental Disorders.

📖 Top 20% JournalArticle

2 days ago • Revue medicale suisse

Using intravenous ketamine for patients in a suicidal crisis: when and how they are referred[Intravenous ketamine in suicidal crisis : indications and patient referral].

English Abstract

3 days ago • Journal of clinical pharmacology

How Ketamine Dose and Treatment Length Relate to Internalizing Mental Health DisordersKetamine Dose and Duration Effects in Internalizing Disorders.

Randomized Controlled Trial

2 days ago • Current opinion in pharmacology

How fluvoxamine works through sigma-1 receptor activation and other actions, and its potential new medical usesPharmacological insights into fluvoxamine maleate: σ1 receptor agonism, multimodal mechanisms, and therapeutic repositioning.

🎖️ Top 10% JournalArticle

4 days ago • Chinese medical journal

Psilocybin can reduce fear and promote brain plasticity in mice without activating 5-HT2A receptors5-HT2A receptor activation is dispensable for psilocybin-induced fear extinction and neuroplasticity in mice.

Article

5 days ago • Cureus

Possible Effects of US FDA Approval of Psychedelic Drugs Like Ibogaine on Japanese PharmaciesImplications of Potential US FDA Approval of Psychedelics or Psychedelic-Adjacents Such as Ibogaine for Pharmacy in Japan.

Article

3 days ago • Journal of psychiatric research

Clinical factors linked to low life engagement in people with treatment-resistant depression who don’t respond to ketamineClinical correlates of non-responders to ketamine in terms of self-assessed life engagement among treatment-resistant depression patients.

Article

5 days ago • Journal of psychiatric practice

Psychiatric Drug Research Shifts from Symptom Groups to Targeted Brain Circuits and Personalized TreatmentsPsychopharmacology at an Inflection Point: From Syndromes to Stratified Mechanisms, Circuit-Based Treatments, and Precision Psychiatry.

Article

4 days ago • Current biology : CB

Ketamine reduces activity in the brain’s aversion center during learning from negative outcomesKetamine attenuates habenula activity in response to aversive outcomes during Pavlovian learning.

Article

6 days ago • Annals of palliative medicine

Quick review of ketamine for easing depression and pain in advanced cancer patientsA rapid systematic review of palliative uses of ketamine for depression and pain in people living with advanced cancer.

Article